Abstract
A very critical feature in women’s health is the identification of risk factors for pregnancy and adverse fetal outcome. Primary biliary cirrhosis is an autoimmune disease of the liver that predominantly affects older women. However, the serologic onset of this disease appears to precede clinical manifestations by many years. The goal of this case controlled study was to analyze fertility in primary biliary cirrhosis (PBC) and investigate the outcome of pregnancy, and the influence of pregnancy on the course of the disease. The study included 233 consecutive female patients with PBC seen between 1987 and 2012. Among them, 186 had at least one conception and were matched for age with a 1:2 group of controls (367 healthy women with at least one conception in their life). PBC patients experienced 507 pregnancies as opposed to 700 pregnancies among controls (mean 1.91 vs 2.73, p < 0.05). The two groups’ life history was similar in terms of miscarriages, voluntary interruptions of pregnancy, and term and preterm deliveries. The rates for one or more cesarean deliveries were lower for PBC patients (5.7 vs 11.7 %, p < 0.05). Pruritus during pregnancy was recorded in 15 pregnancies involving 13 PBC patients (3.0 %) and none of the controls. Perinatal and postnatal deaths and complications at childbirth were only recorded in the PBC patients, involving a total of 11 babies (2.7 %, p < 0.05). Eight pregnancies occurred after PBC was diagnosed in six patients, all of which had a favorable course at term, with no complications at childbirth. Ursodeoxycholic acid was continued during pregnancy and no exacerbation of the disease was observed. In conclusion, successful completion of pregnancy is a realistic expectation for PBC patients, though pregnancy and delivery must be monitored for the potentially higher than normal risk of childbirth complications.
Similar content being viewed by others
Abbreviations
- PBC:
-
Primary biliary cirrhosis
- AMA:
-
Antimitochondrial antibody
- AST:
-
Aminotransferase
- SSc:
-
Systemic sclerosis
- UDCA:
-
Ursodeoxycholic acid
References
Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14:353–356
Candia L, Marquez J, Espinoza LR (2005) Autoimmune hepatitis and pregnancy: a rheumatologist’s dilemma. Semin Arthritis Rheum 35:49–56
Perricone C, de Carolis C, Perricone R (2012) Pregnancy and autoimmunity: a common problem. Best Pract Res Clin Rheumatol 26:47–60
Andreoli L, Fredi M, Nalli C, Reggia R, Lojacono A, Motta M, Tincani A (2012) Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmun 38:J197–J208
Andreoli L, Tincani A (2012) Beyond the “syndrome”: antiphospholipid antibodies as risk factors. Arthritis Rheum 64:342–345
Carp HJ, Selmi C, Shoenfeld Y (2012) The autoimmune bases of infertility and pregnancy loss. J Autoimmun 38:J266–J274
Gleicher N (2014) Maternal autoimmunity and adverse pregnancy outcomes. J Autoimmun 50:83–86
Gleicher N, Weghofer A, Barad DH (2012) Cutting edge assessment of the impact of autoimmunity on female reproductive success. J Autoimmun 38:J74–J80
Iago PF, Albert SO, Andreu FC, Xavier MG, Jose RP, Jordi PL, Miquel VT (2014) “Pregnancy in adult-onset idiopathic inflammatory myopathy”: report from a cohort of myositis patients from a single center. Semin Arthritis Rheum
Jorgensen KT, Nielsen NM, Pedersen BV, Jacobsen S, Frisch M (2012) Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort. J Autoimmun 38:J120–J128
Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, Petri M et al (2012) Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 64:2311–2318
Michael DL, Cohn E, Aslam A, Buyon JP, Salmon JE (2013) Sex ratios among children of lupus pregnancies. Arthritis Rheum 65:282
Noel N, Wechsler B, Nizard J, Costedoat-Chalumeau N, du Boutin LT, Dommergues M, Vauthier-Brouzes D et al (2013) Behcet’s disease and pregnancy. Arthritis Rheum 65:2450–2456
Samarkos M, Mylona E, Kapsimali V (2012) The role of complement in the antiphospholipid syndrome: a novel mechanism for pregnancy morbidity. Semin Arthritis Rheum 42:66–69
Sangle SR, Lutalo PM, Davies RJ, Khamashta MA, D’Cruz DP (2013) B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. J Autoimmun 43:55–59
Taraborelli M, Ramoni V, Brucato A, Airo P, Bajocchi G, Bellisai F, Biasi D et al (2012) Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum 64:1970–1977
Viall CA, Chen Q, Liu B, Hickey A, Snowise S, Salmon JE, Stone PR et al (2013) Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. J Autoimmun 47:45–57
Westbrook RH, Yeoman AD, Kriese S, Heneghan MA (2012) Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 38:J239–J244
Conde-Agudelo A, Villar J, Lindheimer M (2008) Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 198:7–22
Rustveld LO, Kelsey SF, Sharma R (2008) Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J 12:223–242
Danza A, Ruiz-Irastorza G, Khamashta M (2012) Antiphospohlipid syndrome in obstetrics. Best Pract Res Clin Obstet Gynaecol 26:65–76
Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, Zeher MM et al (2009) Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 68:1428–1432
Ostensen M, Villiger PM, Forger F (2012) Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev 11:A437–A446
Williams M, Chakravarty EF (2014) Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy. Curr Opin Rheumatol 26:341–346
Borchers AT, Naguwa SM, Keen CL, Gershwin ME (2010) The implications of autoimmunity and pregnancy. J Autoimmun 34:J287–J299
Cush JJ, Kavanaugh A (2014) Editorial: pregnancy and rheumatoid arthritis—do not let the perfect become the enemy of the good. Curr Opin Rheumatol 26:299–301
Barbhaiya M, Bermas BL (2013) Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. Clin Immunol 149:225–235
Clark CA, Spitzer KA, Laskin CA (2005) Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 32:1709–1712
Talwalkar JA, Lindor KD (2003) Primary biliary cirrhosis. Lancet 362:53–61
Trivedi P, Kumagi T, Al-Harthy N, Coltescu C, Ward S, Cheung A (2014) Good maternal and fetal outcome for pregnant women with primary biliary cirrhosis. Clin Gastroenterol Hepatol in press
Parikh-Patel A, Gold E, Utts J, Gershwin ME (2002) The association between gravidity and primary biliary cirrhosis. Ann Epidemiol 12:264–272
Stellon AJ, Williams R (1986) Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J (Clin Res Ed) 293:297–298
Floreani A, Paternoster D, Mega A, Farinati F, Plebani M, Baldo V, Grella P (2002) Sex hormone profile and endometrial cancer risk in primary biliary cirrhosis: a case-control study. Eur J Obstet Gynecol Reprod Biol 103:154–157
Scheuer P (1967) Primary biliary cirrhosis. Proc R Soc Med 60:1257–1260
Floreani A, Caroli D, Variola A, Rizzotto ER, Antoniazzi S, Chiaramonte M, Cazzagon N et al (2011) A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int 31:361–368
Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF (2004) Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 53:865–870
Strotmeyer ES, Steenkiste AR, Foley TP Jr, Berga SL, Dorman JS (2003) Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 26:1016–1021
Williams CE, Creighton SM (2012) Menstrual disorders in adolescents: review of current practice. Horm Res Paediatr 78:135–143
Cockrill T, del Junco DJ, Arnett FC, Assassi S, Tan FK, McNearney T, Fischbach M et al (2010) Separate influences of birth order and gravidity/parity on the development of systemic sclerosis. Arthritis Care Res (Hoboken) 62:418–424
Launay D, Hebbar M, Hatron PY, Michon-Pasturel U, Queyrel V, Hachulla E, Devulder B (2001) Relationship between parity and clinical and biological features in patients with systemic sclerosis. J Rheumatol 28:509–513
Selmi C, Brunetta E, Raimondo MG, Meroni PL (2012) The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 11:A531–A537
Artlett CM, Rasheed M, Russo-Stieglitz KE, Sawaya HH, Jimenez SA (2002) Influence of prior pregnancies on disease course and cause of death in systemic sclerosis. Ann Rheum Dis 61:346–350
Cresswell JA, Ronsmans C, Calvert C, Filippi V (2013) Prevalence of placenta praevia by world region: a systematic review and meta-analysis. Trop Med Int Health 18:712–724
Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, Nicastri PL et al (2012) Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 143:1492–1501
Rudi J, Schonig T, Stremmel W (1996) Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy. Z Gastroenterol 34:188–191
Poupon R, Chretien Y, Chazouilleres O, Poupon RE (2005) Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J Hepatol 42:418–419
Financial Support
The work was partially supported by a grant from Padova University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Floreani, A., Infantolino, C., Franceschet, I. et al. Pregnancy and Primary Biliary Cirrhosis: A Case-Control Study. Clinic Rev Allerg Immunol 48, 236–242 (2015). https://doi.org/10.1007/s12016-014-8433-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-014-8433-z